loceryl has been researched along with Foot Dermatoses in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (14.29) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 14 (50.00) | 24.3611 |
| 2020's | 3 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Blume-Peytavi, U; Carreño, C; Falqués, M; Galván, J; Tamarit, ML; Tebbs, V; Tosti, A | 1 |
| Barrett, J; Boal, CWC; Brennan, J; Callanan, S; Ehrensberger, M; Makarus, J; Patton, T; Spillane, E | 1 |
| Bunyaratavej, S; Kiratiwongwan, R; Leeyaphan, C; Srinonprasert, V; Wongdama, S | 1 |
| Dyląg, M; Hryncewicz-Gwóźdź, A; Jagielski, T | 1 |
| Sarkany, M; Schaller, M; Sigurgeirsson, B | 1 |
| Artzi, O; Koren, A; Salameh, F; Sprecher, E | 1 |
| Ben Osman, A; Bienvenu, AL; Bulai-Livideanu, C; Cazeau, C; Coubetergues, H; Coustou, D; Doss, N; Fazaa, B; Lahfa, M; Mokthar, I; Nouira, R; Paul, C; Picot, S; Turki, H; Voisard, JJ; Zourabichvili, O | 1 |
| Arendrup, MC; Haugaard, LK; Saunte, DM; Skov, L | 1 |
| Lipner, S; Scher, RK | 1 |
| Chen, S; Dai, YL; Hu, WY; Lama, J; Ran, YP | 1 |
| Auvinen, T; Jokinen, JJ; Sipponen, A; Soini, M; Tiihonen, R; Wangel, M | 1 |
| Borelli, C; Braunsdorf, C; Jäckel, A; Mailänder-Sanchez, D; Müller, J; Schaller, M | 1 |
| Ghannoum, MA; Kerrouche, N; Osman-Ponchet, H; Sidou, F; Sigurgeirsson, B | 1 |
| Budihardja, D; Freund, V; Mayser, P | 1 |
| Kerrouche, N; Olafsson, JH; Sidou, F; Sigurgeirsson, B; Steinsson, JT | 1 |
| Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C | 1 |
| Piraccini, BM; Sisti, A; Tosti, A | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Fidalgo, A; Lobo, L | 1 |
| Adjadj, L; Jäckel, A; Lambert, J; Marty, JP | 1 |
| Adamski, Z; Maleszka, R | 1 |
| Bergstraesser, M; Nolting, S; Reckers-Czaschka, R; Reinel, D; Semig, G; Zaug, M | 1 |
| Cohen, PR; Scher, RK | 1 |
| Badillet, G; Baran, R; Combernale, P; Czernielewski, J; Datry, A; Feuilhade, M; Goettmann, S; Larnier, C; Pietrini, P; Viguie, C | 1 |
| Baran, R | 2 |
| Lecha, M | 1 |
| Reinel, D | 1 |
3 review(s) available for loceryl and Foot Dermatoses
| Article | Year |
|---|---|
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Topical and surgical treatment of onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Combined Modality Therapy; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Onychomycosis; Pyridones | 1994 |
13 trial(s) available for loceryl and Foot Dermatoses
| Article | Year |
|---|---|
A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
Topics: Antifungal Agents; Double-Blind Method; Foot Dermatoses; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Terbinafine; Treatment Outcome | 2022 |
A clinical study for the treatment of onychomycosis patients using a novel ROS producing onychomycosis treatment when compared against 5% amorolfine topical lacquer to reduce the visible size of infected toenails.
Topics: Administration, Topical; Antifungal Agents; Foot Dermatoses; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Reactive Oxygen Species; Treatment Outcome | 2022 |
Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Imidazoles; Lacquer; Male; Medication Adherence; Middle Aged; Morpholines; Onychomycosis; Patient Reported Outcome Measures; Pyridones | 2017 |
Laser-assisted Photodynamic Therapy or Laser-assisted Amorolfine Lacquer Delivery for Treatment of Toenail Onychomycosis: An Open-label Comparative Study.
Topics: Adult; Aged; Aminolevulinic Acid; Antifungal Agents; Female; Foot Dermatoses; Humans; Lacquer; Lasers, Gas; Male; Middle Aged; Morpholines; Onychomycosis; Photochemotherapy; Photosensitizing Agents; Remission Induction; Time Factors; Treatment Outcome | 2018 |
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in
Topics: Adolescent; Adult; Aged; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Ointments; Onychomycosis; Pyridones; Retrospective Studies; Skin Cream; Time Factors; Treatment Outcome; Young Adult | 2013 |
Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Lacquer; Male; Morpholines; Naphthalenes; Onychomycosis; Prospective Studies; Resins, Plant; Single-Blind Method; Terbinafine; Treatment Outcome; Young Adult | 2015 |
Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.
Topics: Adult; Aged; Antifungal Agents; Cadaver; Cosmetics; Female; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Onychomycosis | 2016 |
Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Lacquer; Longitudinal Studies; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Pilot Projects; Secondary Prevention; Terbinafine; Treatment Outcome | 2010 |
Amorolfine spray in the treatment of foot mycoses (a dose-finding study).
Topics: Adult; Aerosols; Antifungal Agents; Candidiasis; Dermatomycoses; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Morpholines; Ointments; Safety; Sensation Disorders; Skin Diseases; Tinea Pedis | 1993 |
A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Drug Synergism; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 2000 |
Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Foot Dermatoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine | 2001 |
Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drug Costs; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Morpholines; Onychomycosis; Treatment Outcome; Trichophyton | 2001 |
Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Tolerance; Female; Foot Dermatoses; Humans; Lacquer; Male; Middle Aged; Morpholines; Onychomycosis; Random Allocation | 1992 |
12 other study(ies) available for loceryl and Foot Dermatoses
| Article | Year |
|---|---|
Onychomycosis in older adults: The age and associated factors affecting the complete cure rate.
Topics: Aged; Antifungal Agents; Antihypertensive Agents; Cohort Studies; Female; Foot Dermatoses; Humans; Kidney Diseases; Male; Middle Aged; Morpholines; Onychomycosis; Peripheral Arterial Disease; Polypharmacy; Retrospective Studies; Sex Factors; Smoking; Thailand | 2022 |
Onychomycosis Due to Arthrinium arundinis: A Case Report.
Topics: Adult; Antifungal Agents; Ascomycota; Drug Therapy, Combination; Foot Dermatoses; Humans; Itraconazole; Male; Microscopy, Electron, Scanning; Morpholines; Onychomycosis; Remission Induction; Treatment Outcome | 2017 |
[Onychomycosis is rare in young children, and treatment is a task for dermatological specialists].
Topics: Antifungal Agents; Child, Preschool; Female; Foot Dermatoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Trichophyton | 2013 |
Onychomycosis: current and future therapies.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles | 2014 |
Case of infantile onychomycosis successfully cured by 5% amorolfine nail lacquer.
Topics: Administration, Topical; Follow-Up Studies; Foot Dermatoses; Humans; Infant; Lacquer; Male; Morpholines; Onychomycosis; Severity of Illness Index; Treatment Outcome | 2014 |
Comparison of user-friendliness and treatment cost of Loceryl® vs. Ciclopoli®--a patient's perspective.
Topics: Administration, Topical; Adult; Antifungal Agents; Ciclopirox; Foot Dermatoses; Germany; Health Care Costs; Humans; Male; Morpholines; Nails; Onychomycosis; Patient Satisfaction; Prospective Studies; Pyridones; Surveys and Questionnaires | 2015 |
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine | 2010 |
Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
Topics: Adult; Aged; Antifungal Agents; Arthrodermataceae; Female; Foot Dermatoses; Humans; Itraconazole; Lacquer; Male; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Treatment Outcome | 2010 |
Allergic contact dermatitis due to amorolfine nail lacquer.
Topics: Adult; Allergens; Cosmetics; Dermatitis, Allergic Contact; Diagnosis, Differential; Female; Foot Dermatoses; Humans; Morpholines; Nails; Patch Tests | 2004 |
Treatment costs of three nail lacquers used in onychomycosis.
Topics: Adult; Antifungal Agents; Ciclopirox; Drug Costs; Europe; Female; Foot Dermatoses; Hand Dermatoses; Humans; Imidazoles; Male; Morpholines; Onychomycosis; Pyridones | 2005 |
[The treatment of extensive onychomycosis in aged patients].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Morpholines; Nails; Onychomycosis; Treatment Outcome | 2001 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones | 1992 |